Status:

UNKNOWN

Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic Neoplasms

Lead Sponsor:

Singapore General Hospital

Conditions:

Pancreatic Cancer

Pancreatic Neoplasms

Eligibility:

All Genders

21-99 years

Phase:

NA

Brief Summary

This study aims to evaluate the safety and efficacy of new ablation catheter developed by MEDICAL TAEWOONG for the treatment of pancreatic neoplasm (pancreatic adenocarcinoma or neuroendocrine tumour)...

Detailed Description

RFA causes tissue destruction through the application of a high frequency alternating current, generating local temperatures above 60°C and leading to coagulative necrosis. The technique has been wide...

Eligibility Criteria

Inclusion

  • Age 21 years-old or above
  • Suffering from pancreatic neuroendocrine tumour or pancreatic ductal carcinoma that was confirmed by fine needle aspiration cytology
  • Unsuitable for surgery, due to one (or more) of the following items:
  • ASA score \>/= III
  • An alternative advanced malignancy
  • Unsuitable for surgery upon expert's opinion for any other reason
  • Individuals who are not keen for surgical resection
  • Eligible for endoscopic intervention
  • Written informed consent

Exclusion

  • Coagulopathy (international normalized ratio \>1.5, partial thromboplastin time greater than twice that of control), platelet count \<50,000x103/uL
  • Pregnancy
  • Patients with a poor mental condition or mental retardation, unable to understand the nature and possible consequences of the study
  • Patients unwilling to undergo follow-up assessments
  • Patients with liver cirrhosis, portal hypertension and/or gastric varices.

Key Trial Info

Start Date :

March 1 2018

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2019

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT03435770

Start Date

March 1 2018

End Date

September 1 2019

Last Update

February 20 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Singapore General Hospital

Singapore, Singapore, 169856